IRIS
TROMBETTA, CLAUDIA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.962
NA - Nord America 7.245
AS - Asia 4.177
SA - Sud America 849
Continente sconosciuto - Info sul continente non disponibili 422
AF - Africa 206
OC - Oceania 7
Totale 20.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.058
GB - Regno Unito 2.948
IT - Italia 1.562
RU - Federazione Russa 1.384
SG - Singapore 1.308
CN - Cina 1.170
BR - Brasile 700
IE - Irlanda 678
VN - Vietnam 560
HK - Hong Kong 355
FR - Francia 278
SE - Svezia 265
DE - Germania 235
KR - Corea 208
UA - Ucraina 180
FI - Finlandia 167
BD - Bangladesh 146
IN - India 138
CA - Canada 91
ZA - Sudafrica 75
AR - Argentina 62
NL - Olanda 50
MX - Messico 49
TR - Turchia 44
IQ - Iraq 40
PL - Polonia 39
AT - Austria 38
CI - Costa d'Avorio 37
ES - Italia 32
JP - Giappone 27
ID - Indonesia 26
BE - Belgio 22
MA - Marocco 21
CO - Colombia 20
EC - Ecuador 20
NG - Nigeria 19
KE - Kenya 18
PK - Pakistan 18
CZ - Repubblica Ceca 16
JM - Giamaica 15
LT - Lituania 14
PH - Filippine 14
VE - Venezuela 12
CL - Cile 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
SA - Arabia Saudita 10
CR - Costa Rica 9
JO - Giordania 9
PE - Perù 9
AZ - Azerbaigian 8
EG - Egitto 8
MY - Malesia 8
PY - Paraguay 8
AL - Albania 7
IR - Iran 7
OM - Oman 7
IL - Israele 6
LB - Libano 6
NP - Nepal 6
AU - Australia 5
CH - Svizzera 5
DK - Danimarca 5
DZ - Algeria 5
HU - Ungheria 5
RO - Romania 5
TN - Tunisia 5
ET - Etiopia 4
GT - Guatemala 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
UY - Uruguay 4
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
GR - Grecia 3
HN - Honduras 3
MD - Moldavia 3
SC - Seychelles 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
Totale 20.424
Salva come PNG Salva come JPEG
Città #
Southend 2.802
Dallas 1.230
Dublin 669
Singapore 659
Ashburn 545
Santa Clara 461
Fairfield 452
Moscow 375
Milan 369
Chandler 354
Hong Kong 331
Council Bluffs 325
Hefei 303
San Jose 281
Siena 279
Beijing 266
Woodbridge 236
Seoul 208
Seattle 206
Houston 196
Wilmington 167
Ho Chi Minh City 163
Ann Arbor 155
Los Angeles 150
Rome 142
Jacksonville 141
Cambridge 131
Dong Ket 113
Hanoi 110
The Dalles 99
Lauterbourg 94
New York 90
Princeton 87
Helsinki 84
Munich 80
Johannesburg 65
Florence 64
Columbus 59
Buffalo 57
Lappeenranta 56
São Paulo 53
San Diego 49
Bengaluru 47
Boardman 43
Orem 43
Shanghai 43
Nanjing 42
Chicago 40
San Mateo 39
Abidjan 37
Redondo Beach 33
Warsaw 33
Nuremberg 32
Frankfurt am Main 30
Montreal 30
Phoenix 30
London 29
Toronto 28
Figino 25
Dearborn 24
Baghdad 23
Brooklyn 23
Tokyo 23
Denver 22
Bari 21
Rio de Janeiro 21
Stockholm 21
Vienna 21
Brussels 20
Da Nang 20
Livorno 20
Chennai 19
Guangzhou 18
Haiphong 18
Abuja 17
Málaga 17
Nanchang 17
Shenyang 17
Turin 17
Belo Horizonte 16
Brasília 15
Brescia 15
Manchester 15
San Francisco 15
Mexico City 14
Portsmouth 14
Tianjin 14
Amsterdam 13
Boydton 13
Piscataway 13
Redwood City 13
Washington 13
Bologna 12
Dhaka 12
Hải Dương 12
Kunming 12
Mumbai 12
Porto Alegre 12
Turku 12
Atlanta 11
Totale 14.037
Salva come PNG Salva come JPEG
Nome #
"OKKIO alla salute 2014" results from the Tuscan sample 696
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 640
The virucidal potential effects of violet-blue light on influenza D virus 567
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 550
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 486
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 464
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 428
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 355
Egg-Independent Influenza Vaccines and Vaccine Candidates 334
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 302
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 298
Challenges in the development of egg-independent vaccines for influenza 279
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 276
Emerging influenza strains in the last two decades: A threat of a new pandemic? 272
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 263
Influenza immunology evaluation and correlates of protection: a focus on vaccines 263
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 262
Solubilization methods and reference 2-DE map of cow milk fat globules 246
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 245
In Vitro Antiviral and Virucidal Activity of Ozone against Feline Calicivirus 239
Impact of erythrocyte species on assays for influenza serology 239
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 231
Influenza vaccines: Evaluation of the safety profile 213
Measles in pregnancy: a threat for Italian women? 210
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 208
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 207
Elettroforesi bidimensionale 207
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 202
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 201
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 195
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 195
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 194
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 191
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 190
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 189
Water and air ozone treatment as an alternative sanitizing technology 184
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 182
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 182
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 182
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 179
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 177
Immunoproteomics of myasthenia 177
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 177
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 176
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 175
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 173
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 171
Evaluating influenza vaccines: Progress and perspectives 167
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 166
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 165
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 165
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 165
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region 164
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy 164
Is influenza A/H10N8 a potential candidate for the next pandemic? 161
There is a correlation between nutritional status, Self-Rated Health and Life Satisfaction? Evidence from 2018 Health Behaviour in School-aged Children cross sectional study in a sample of Italian adolescents living in Tuscany Region 157
Trend della prevalenza di sovrappeso e obesità nei bambini toscani in età scolare dal 2002 al 2016 [Trends of overweight and obesity prevalence among schoolchildren in Tuscany Region (Central Italy), period 2002-2016] 156
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 154
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 154
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 153
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 152
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 150
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 143
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 141
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 141
Tecnologie per l'analisi del proteoma 140
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 139
Low prevalence of antibodies against pertussis in pregnant women in Italy 139
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines 138
null 136
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 135
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 135
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 135
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 133
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 133
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 133
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 130
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 127
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 125
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study 124
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 124
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 123
Assessment of Pertussis Underreporting in Italy 120
Seroprevalence of hepatitis e virus in forestry workers from trentino-alto adige region (Northern Italy) 120
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 119
Sorveglianza virologica della nuova variante del virus influenzale A/H1N1 nell’Area Vasta Toscana sud 119
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 118
null 116
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 114
Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy 113
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 112
Assessing the virucidal activity of essential oils against feline calicivirus, a non-enveloped virus used as surrogate of norovirus 110
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 110
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination 109
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 109
Measles Susceptibility in Apulia: The Italian Mirror? 108
Virucidal Activity of Lemon Essential Oil against Feline Calicivirus Used as Surrogate for Norovirus 107
Virucidal activity in vitro of mouthwashes against a feline coronavirus type II 104
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 103
In vitro virucidal activity of mouthwashes on SARS-CoV-2 102
Totale 19.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022981 0 177 143 98 49 35 52 37 61 78 95 156
2022/20231.154 67 144 137 144 100 207 44 101 123 32 33 22
2023/20241.134 36 42 90 45 42 251 437 21 13 53 15 89
2024/20253.228 62 227 301 218 366 223 106 162 317 127 315 804
2025/20268.531 620 916 1.261 1.035 1.363 320 825 255 371 497 363 705
2026/2027710 490 220 0 0 0 0 0 0 0 0 0 0
Totale 20.868